Binance Labs has announced its investment in BIO Protocol, a pioneering project that seeks to revolutionize the financing and commercialization of early-stage scientific research through blockchain technology. This marks Binance Labs' first foray into the Decentralized Science (DeSci) sector, highlighting the lab’s commitment to supporting groundbreaking advancements in technology that promise real-world impact.
BIO Protocol operates as an innovative platform that enables scientists, patients, and investors worldwide to fund, develop, and co-own medical advancements through a network of Biotech Decentralized Autonomous Organizations (BioDAOs). The platform addresses key funding gaps in scientific research, with a particular focus on rare diseases, longevity research, and other emerging health challenges. With seven existing BioDAOs exploring diverse areas—from cryopreservation to mental health treatments—the platform’s next projects will tackle Long COVID, rare diseases, and quantum biology, expanding the community-driven reach of scientific research.
"BIO Protocol represents a significant step forward in DeSci by merging biotechnology and DeFi," said Andy Chang, Investment Director at Binance Labs. "Our commitment is to drive real, long-term impact by investing in projects that build meaningful technology. Supporting BIO Protocol aligns with our mission to foster innovation that can truly shape the future and unlock scientific breakthroughs across the globe."
